The regulatory filing process for a Hong Kong IPO usually begins with the appointment of a sponsor. Sponsors are licensed intermediaries registered with the SFC and are responsible for guiding the applicant through pre-listing requirements. Their tasks may involve coordinating financial audits, collating necessary disclosures, and ensuring overall readiness for regulatory review. Sponsor engagement is considered mandatory for both Main Board and GEM listings.

Once preparatory work is complete, the company and sponsor jointly submit a listing application to HKEX. This application typically includes a draft listing document, financial statements audited by a registered Hong Kong auditor, and the sponsor’s due diligence report. The regulatory review period—with input from both HKEX and SFC—can take several months, as exchanges often seek clarifications or additional materials from the applicant to verify disclosures.
During the review process, the HKEX may arrange for meetings with management to better understand the company’s business, governance, and financial practices. Queries from regulators are common, covering matters such as internal controls, related-party transactions, and business risk management. The applicant, with support from its advisers, is expected to respond promptly and substantiate all claims made in the draft prospectus.
Following satisfactory clearance of regulatory queries, the exchange grants approval-in-principle for the listing. The company may then publish its full prospectus, commence investor roadshows, and ascertain public interest. Only upon completion of these final steps will the shares be formally listed and trading initiated. This multi-stage approach aims to protect investors and ensure only qualified companies access public capital markets.